Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams
Pace of Nociscan orders accelerated 2.5x for the last 250 scans compared to the first 250 scans
Further acceleration of scan volumes expected as MRIs are activated for the recently completed panel of 10 Key Opinion Leader (KOL) surgeons
Related news for (ACON)
- First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
- Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site
- Aclarion Announces Texas Back Institute as New CLARITY Trial Site
- Aclarion Welcomes Advocate Health as CLARITY Trial Site
- Aclarion Announces Commercial Agreement with Spine Institute of Louisiana